Response to trabectedin treatment in a highly pretreated patient with an advanced meningeal hemangiopericytoma

被引：9
|
作者：
Martinez-Trufero, Javier [1 ]
Alfaro, Jorge [2 ]
Felipo, Francesc [2 ]
Alvarez, Maria [1 ]
Madani, Julia [1 ]
Cebollero, Ana [1 ]
机构：
[1] Hosp Univ Miguel Servet, Dept Med Oncol, Zaragoza 50009, Spain
[2] Hosp Univ Miguel Servet, Dept Pathol, Zaragoza 50009, Spain
来源：
ANTI-CANCER DRUGS | 2010年 / 21卷 / 08期
关键词：
hemangiopericytoma; rare tumor; solitary fibrous tumor; trabectedin; SOFT-TISSUE SARCOMA; CENTRAL-NERVOUS-SYSTEM; MALIGNANT HEMANGIOPERICYTOMA; PHASE-II; FIBROUS TUMOR; ECTEINASCIDIN-743; CHEMOTHERAPY; RADIOTHERAPY; EXPERIENCE; SUNITINIB;
D O I：
10.1097/CAD.0b013e32833d19f0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Meningeal hemangiopericytoma is an uncommon and aggressive malignancy that, in contrast to meningiomas, shows a high propensity for local recurrence and the development of late extraneural metastases. The results of chemotherapy in advanced hemangiopericytoma have been disappointing, and they have been particularly poor in cases located in the meninges. We report a case of a heavily pretreated metastatic meningeal hemangiopericytoma in which fourth-line chemotherapy with trabectedin, a marine-derived antineoplastic agent effective in treating advanced soft tissue sarcomas, resulted in clinical benefit. Anti-Cancer Drugs 21: 795-798 (C) 2010 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码：795 / 798
页数：4
相关论文
共 50 条
  • [31] Experience with Trabectedin in an Advanced Sarcoma Patient on Peritoneal Dialysis for End-Stage Renal Failure
    Moe, Maung Maung Myat
    Fernandez Teruel, Carlos
    Soto-Matos, Arturo
    CHEMOTHERAPY, 2013, 59 (06) : 458 - 460
  • [32] Retrospective inter- and intra-patient evaluation of trabectedin after best supportive care for patients with advanced translocation-related sarcoma after failure of standard chemotherapy
    Araki, Nobuhito
    Takahashi, Shunji
    Sugiura, Hideshi
    Ueda, Takafumi
    Yonemoto, Tsukasa
    Takahashi, Mitsuru
    Morioka, Hideo
    Hiraga, Hiroaki
    Hiruma, Toru
    Kunisada, Toshiyuki
    Matsumine, Akihiko
    Kawai, Akira
    EUROPEAN JOURNAL OF CANCER, 2016, 56 : 122 - 130
  • [33] Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report
    Nteli, Viktoria-Anna
    Knauf, Wolfgang
    Janton-Klein, Anja
    El-Safadi, Samer
    CASE REPORTS IN ONCOLOGY, 2018, 11 (01): : 81 - 89
  • [34] The role of trabectedin as second-line treatment of advanced soft tissue sarcoma: update of key efficacy and safety data
    Le Cesne, Axel
    FUTURE ONCOLOGY, 2022, 18 (30S) : 1 - 3
  • [35] Radiological evaluation of response in patients with locally advanced/metastatic soft tissue sarcoma treated with trabectedin
    Ceddia, S.
    Onesti, C. E.
    Vari, S.
    Torchia, A.
    Cosimati, A.
    Riva, F.
    Maccallini, M. T.
    Cerro, M.
    Benvenuti, G.
    Russillo, M.
    Anelli, V.
    Sperduti, I.
    Biagini, R.
    Ferraresi, V.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [36] Long-term remission in a patient with heavily pretreated, advanced ovarian cancer achieved by bevacizumab and metronomic cyclophosphamide treatment
    Aigner, Julia
    Bischofs, Esther
    Hallscheidt, Peter
    Sohn, Christof
    Schneeweiss, Andreas
    Eichbaum, Michael
    ANTI-CANCER DRUGS, 2011, 22 (10) : 1030 - 1033
  • [37] A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer
    Zelek, L.
    Yovine, A.
    Brain, E.
    Turpin, F.
    Taamma, A.
    Riofrio, M.
    Spielmann, M.
    Jimeno, J.
    Misset, J. L.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1610 - 1614
  • [38] A phase II study of Yondelis® (trabectedin, ET-743) as a 24-h continuous intravenous infusion in pretreated advanced breast cancer
    L Zelek
    A Yovine
    E Brain
    F Turpin
    A Taamma
    M Riofrio
    M Spielmann
    J Jimeno
    J L Misset
    British Journal of Cancer, 2006, 94 : 1610 - 1614
  • [39] Colorectal cancer: response to sunitinib in a heavily pretreated colorectal cancer patient
    Gasent Blesa, Joan Manel
    Grande Pulido, Enrique
    ANTI-CANCER DRUGS, 2010, 21 : S23 - S26
  • [40] Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes
    Di Tommaso, Monica
    Rosa, Consuelo
    Caravatta, Luciana
    Augurio, Antonietta
    Borzillo, Valentina
    Di Santo, Sara
    Perrotti, Francesca
    Taraborrelli, Maria
    Cianci, Roberta
    Innocenti, Paolo
    Di Sebastiano, Pierluigi
    Colasante, Antonella
    Angelucci, Domenico
    Basti, Massimo
    Sindici, Giulia
    Mazzola, Lorenzo
    Pizzicannella, Giuseppe
    Di Bartolomeo, Nicola
    Marchioni, Michele
    Di Nicola, Marta
    Genovesi, Domenico
    IN VIVO, 2020, 34 (03): : 1223 - 1233
12345